11 completed, 3 terminated, 2 unknown, 2 withdrawn. 7 Phase 1, 5 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 3, Terminated 3, Withdrawn 1 |
| Phase 2 | 5 | Completed 3, Terminated 2 |
| Not applicable | 1 | Withdrawn 1 |
Follow Western blot: new trials by email Literature Review of Western blot trials Research Report on Western blot
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Circulating MrgD in Pulmonary Hypertension Western blot - Pulmonary Hypertension | Unknown | Qilu Hospital of Shandong University | 90 | 2024-04-10 | 2024-04-15 | |
| Improvement of DIAgnostic and Phenotype-genotype Correlation Studies in Patients With MYOpathy Suspected of TITinopathy Western blot, Protein interaction studies, Mass Spectometry - Myopathy, Phenotypic Abnormality | Unknown | University Hospital, Montpellier | 50 | 2019-12-05 | 2024-02-28 | |
| Efficacy of Heat-shock Protein (HSP) Inhibitors in Myeloproliferative Syndromes (MPS) Blood sample, Flow cytometry, western blot - Myeloproliferative Syndrome | Completed | Centre Hospitalier Universitaire Dijon | 37 | 2015-01-01 | 2016-08-22 | |
| Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies fludarabine phosphate, methoxyamine, laboratory biomarker analysis - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 1 | Completed | Case Comprehensive Cancer Center | 20 | 2011-05-01 | 2015-08-13 |
| Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma panobinostat, laboratory biomarker analysis, western blotting - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 2 | Completed | Mayo Clinic | 41 | 2011-01-17 | 2022-05-24 |
| Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery azacitidine, laboratory biomarker analysis, immunohistochemistry staining method - Recurrent Breast Cancer, Stage IA Breast Cancer | Not applicable | Withdrawn | University of Southern California | 2011-01-01 | 2014-02-06 | |
| Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases bafetinib, microdialysis, pharmacological study - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma | Phase 1 | Completed | City of Hope Medical Center | 7 | 2010-12-01 | 2018-04-17 |
| Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia laboratory biomarker analysis, western blotting, gene expression analysis - Refractory Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia | Phase 1 | Withdrawn | Roswell Park Cancer Institute | 2010-12-01 | 2014-01-13 | |
| Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia entinostat, imatinib mesylate, laboratory biomarker analysis - Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 2 | 2010-10-01 | 2017-08-08 |
| Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy panobinostat, fluorouracil, leucovorin calcium - Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 1 | Terminated | University of Southern California | 7 | 2010-10-01 | 2015-05-27 |
| Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome bortezomib, belinostat, laboratory biomarker analysis - Acute Lymphocytic Leukemia, Acute Myeloid Leukemia | Phase 1 | Completed | Virginia Commonwealth University | 41 | 2010-05-01 | 2016-04-15 |
| Molecular Mechanisms of the Development of Precancerous and Cancerous Lesions of the Oral Cavity global proteomic profiling - Oral Lichen Planus, Oral Squamous Cell Carcinoma | Completed | University of Zagreb | 71 | 2010-01-01 | 2017-01-20 | |
| Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer Diagnostic Laboratory Biomarker Analysis, Immunohistochemistry Staining Method, Medical Chart Review - Endometrial Serous Adenocarcinoma, Stage I Uterine Corpus Cancer | Completed | Gynecologic Oncology Group | 360 | 2010-01-01 | 2024-08-14 | |
| Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone Lymphoma pegfilgrastim, rituximab, flow cytometry - Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma | Phase 2 | Completed | Roswell Park Cancer Institute | 20 | 2007-04-17 | 2017-10-09 |
| Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer sorafenib tosylate, microarray analysis, immunohistochemistry staining method - Adenocarcinoma of the Prostate, Stage II Prostate Cancer | Phase 2 | Completed | University of Washington | 5 | 2006-12-01 | 2017-11-22 |
| Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma nelfinavir mesylate, biopsy, laboratory biomarker analysis - Adult Liposarcoma, Recurrent Adult Soft Tissue Sarcoma | Phase 1 / Phase 2 | Terminated | City of Hope Medical Center | 29 | 2006-03-01 | 2015-04-01 |
| Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer DNA/RNA sequencing and expression levels, Protein expression analysis, Lung tumor biopsy - Lung Cancer | Completed | Vanderbilt-Ingram Cancer Center | 204 | 2005-12-01 | 2017-07-19 | |
| The Effect of When Medication is Taken on Nutritional Status in Hospitalized Patients Older Than 65 Years Blood sample, Flow cytometry, western blot - Nutritional Status | Completed | Centre Hospitalier Universitaire Dijon | 30 | 2016-09-09 |
Leukemia, Lymphocytic, Chronic, B-Cell (4) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (4) · Lymphoma, B-Cell, Marginal Zone (3) · Lymphoma, Follicular (3) · Burkitt Lymphoma (2) · Immunoblastic Lymphadenopathy (2) · Lymphoma, Extranodal NK-T-Cell (2) · Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Large-Cell, Anaplastic (2) · Lymphoma, Mantle-Cell (2) · Lymphoma, T-Cell, Peripheral (2) · Mycosis Fungoides (2) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (2) · Sezary Syndrome (2) · Waldenstrom Macroglobulinemia (2)
Centre Hospitalier Universitaire Dijon (2) · City of Hope Medical Center (2) · Roswell Park Cancer Institute (2) · University of Southern California (2) · Case Comprehensive Cancer Center (1) · Gynecologic Oncology Group (1) · Mayo Clinic (1) · National Cancer Institute (NCI) (1) · Qilu Hospital of Shandong University (1) · University Hospital, Montpellier (1) · University of Washington (1) · University of Zagreb (1) · Vanderbilt-Ingram Cancer Center (1) · Virginia Commonwealth University (1)
United States (11) · France (3) · China (1) · Croatia (1)
Agustin Garcia, MD (1) · Asher Chanan-Khan (1) · Barbara Buttin (1) · Beata Holkova, MD (1) · Christine Lovly, MD, PhD (1) · Evan Yu (1) · Francisco Hernandez-ILizaliturri (1) · Heinz-Josef Lenz (1) · Jana Portnow (1) · Marinka Mravak-Stipetic, Professor (1) · Paolo Caimi, MD (1) · Patrick Brown (1) · Patrick Johnston, M.D. (1) · Steven Grant (1) · Warren Chow (1)
PMID 12543777, PMID 19037107, PMID 21743296, PMID 23380277
P30CA068485 (1), P50CA090949 (1), R21CA135467 (1), RC2CA148431 (1), U01CA070095 (1), U10CA027469 (1), U10CA037517 (1)